Pediatric Cardiac Genomics Consortium (U01 - Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The purpose of this funding opportunity announcement (FOA) is to invite applications to participate as a Research Center in the Pediatric Cardiac Genomics Consortium (PCGC). The PCGC’s mission is to identify genetic causes of human congenital heart disease (CHD) and to relate genetic variants in patients with CHD to clinical outcomes through collaborative, multi-center studies. The PCGC fosters investigation along the translational spectrum of CHD research through interactions with Cardiovascular Developmental Biology Data Resource Center (CDDRC, previously the Cardiovascular Development Consortium) and the Pediatric Heart Network (PHN). Together, they constitute the Bench to Bassinet Program (B2B). Sites not currently part of the PCGC are encouraged to apply and propose new directions for the consortium.

Companion FOAs:

RFA-HL-20-017U01 Research Project - Cooperative Agreements

RFA-HL-21-002U01 Research Project - Cooperative Agreements


  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • Application Due Date(s): October 2, 2019

RFA0HL-20-015 Expiration Date October 3, 2019

Agency Website

Amount Description

Application budgets are limited to $275,000 direct costs per year in fiscal years 2020 to 2024 to support research infrastructure. Protocol budgets should be commensurate with the scope and complexity of the protocol.

Funding Type





Medical - Clinical Science
Medical - Translational

External Deadline

October 2, 2019